Skip to main content

Study

Chromium Supplementation May Improve Insulin Resistance in Older Adults with Type 2 Diabetes

A study found that taking 400 micrograms of chromium daily can reduce insulin resistance in adults over 40 with type 2 diabetes.

Diabetes & Blood SugarNutrition
Study Credibility: High8.4/10From a trusted journalProperly designed studyResults verified
PublishedMar 2026Last reviewedOct 2026
Email this

Summary

In plain language

Recent research has shown that supplementing with chromium can help improve insulin resistance in older adults with type 2 diabetes. The study involved adults over the age of 40 who took 400 micrograms of chromium daily for eight weeks. While the chromium supplementation did not significantly lower fasting blood glucose levels, it did result in a noticeable reduction in insulin resistance. This finding is important because managing insulin resistance can help prevent further complications associated with diabetes. Seniors with type 2 diabetes may want to discuss with their healthcare providers whether chromium supplementation could be a beneficial addition to their diabetes management plan.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study was a controlled trial where participants with type 2 diabetes were given chromium or a placebo for eight weeks. Researchers measured cholesterol and insulin resistance, finding improvements in those taking chromium.

  • The study found a significant reduction in total cholesterol and insulin resistance in the chromium group.

  • No significant changes were observed in fasting blood glucose or body weight.

  • The study had a small sample size, and results may differ with larger groups or higher doses.

Seniors should discuss adding chromium supplements with their healthcare providers, especially if managing diabetes.

Research Quality Score

Scored October 22, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study scores highly due to its rigorous randomized controlled trial design, strong bias control measures, and comprehensive reporting. However, the lack of replication evidence and unspecified journal quality limit the overall score. The study's relevance is partial as it includes patients over 40 but not specifically seniors aged 55+.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control10.0/10
Statistical methods10.0/10
Reporting completeness10.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population5.0/10
Journal Reliability5.0/10

Additional Notes

This randomized, double-blind, placebo-controlled trial evaluated the effects of chromium supplementation on insulin resistance and lipid profiles in patients with type 2 diabetes. Chromium supplementation improved LDL-C, total cholesterol, and HOMA-IR but did not significantly affect fasting blood glucose levels.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.